@ARTICLE{
author={Matic Ivana Z,Grujic Milica,Kolundzija Branka S,Damjanovic Ana B,Tomasevic Zorica I,Djordjic-Crnogorac Marija J,Dzodic Radan R,Filipovic-Ljeskovic Ivana M,Zdrale Zdravko,Eric-Nikolic Aleksandra M,Juranic Zorica D},
year={2021},
title={White blood cell subsets in HER2-positive breast cancer patients treated with trastuzumab in relation to clinical outcome},
journal={PATHOLOGY RESEARCH AND PRACTICE},
volume={224},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Tomasevic Zorica I,Tomasevic Zoran M,Bozovic-Spasojevic Ivana M,Serovic Kristina,Stojanovic Aleksandar,Zdrale Zdravko,Neric Dobrica,Kovac Zeljko},
year={2016},
title={Family and personal cancer history in young patients with pregnancy associated breast cancer.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={34},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Tomasevic Zorica I,Bozovic-Spasojevic Ivana M,Serovic Kristina,Stojanovic Aleksandar,Zdrale Zdravko},
year={2016},
title={Durable disease control in patients with metastatic breast cancer treated with single agent capecitabine.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={34},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Tomasevic Zorica I,Neric Dobrica,Milosevic Snezana,Bozovic-Spasojevic Ivana M,Zdrale Zdravko,Sarcevic Aleksandra,Kolarevic Daniela},
year={2015},
title={Durable Remissions with Trastuzumab Treatment for Her2 Positive Metastatic Breast Cancer - Single Center Experience},
journal={BREAST},
volume={24},
number={},
pages={S42-S42},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Tomasevic Zoran M,Kovac Zeljko,Milovanovic Zorka M,Minic Ivana Z,Milosevic Snezana,Bozovic-Spasojevic Ivana M,Zdrale Zdravko,Markovic Ivan Z,Dzodic Radan R},
year={2015},
title={Young patients with breast cancer: Comparison of molecular characteristics of pregnancy associated breast cancer with non-pregnancy associated breast cancer},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={33},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Milovanovic Zorka M,Tomasevic Zoran M,Bozovic-Spasojevic Ivana M,Milosevic Snezana,Zdrale Zdravko,Andjelic-Dekic Natasa,Kovac Zeljko},
year={2015},
title={Histology and molecular characteristics of pregnancy associated breast cancer},
journal={ANNALS OF ONCOLOGY},
volume={26},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Matic Ivana Z,Grujic M,Kolundzija Branka S,Damjanovic-Velickovic Ana,Tomasevic Zoran M,Bozovic-Spasojevic Ivana M,Dzodic Radan R,Zdrale Zdravko,Juranic Zorica D},
year={2014},
title={Changes of the white blood cells subsets in HER2 positive breast cancer patients treated with trastuzumab},
journal={EUROPEAN JOURNAL OF CANCER},
volume={50},
number={},
pages={S214-S214},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Troeger Wilfried,Zdrale Zdravko,Tisma Nevena,Matijasevic Miodrag M},
year={2014},
title={Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial},
journal={EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE},
volume={},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Zdrale Zdravko},
year={2013},
title={Significance of value of biomarkers troponine I and NT-proBNP in evaluation of potential cardiotoxicity of Trastuzumab in patients with HER2 positive breast cancer},
journal={EUROPEAN JOURNAL OF HEART FAILURE},
volume={12},
number={},
pages={S288-S289},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Matijasevic Miodrag M,Zdrale Zdravko,Milosevic Snezana,Tomasevic Zorica I},
year={2011},
title={Assessing the Cognitive Function Among the Breast Cancer Patient After Chemotherapy Treatment},
journal={EUROPEAN JOURNAL OF CANCER},
volume={47},
number={},
pages={S361-S362},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Rakocevic Z,Milosevic Snezana,Tomasevic Zorica I,Zdrale Zdravko,Vasovic Suzana,Matijasevic Miodrag M,Borojevic Nenad D,Lukic Vesna},
year={2008},
title={Patterns of relapse during adjuvant trastuzumab therapy},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={26},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Matijasevic Miodrag M,Arsenijevic Jelena,Milosevic Snezana,Zdrale Zdravko,Tomasevic Zorica I},
year={2008},
title={Cognitive Function In Women with Breast Cancer After Chemotherapy Treatment},
journal={NEURO-ONCOLOGY},
volume={10},
number={6},
pages={1123-1123},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Zdrale Zdravko,Matijasevic Miodrag M},
year={2008},
title={Severe skin toxicity observed in patients (pts) treated with capecitabine (CAP) and weekly paclitaxel (PACLI) for metastatic breast cancer (MBC)},
journal={EJC SUPPLEMENTS},
volume={6},
number={7},
pages={200-200},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Popov Ivan P,Jelic Svetislav B,Krivokapic Zoran V,Micev Marjan T,Babic Dragana,Zdrale Zdravko},
year={2006},
title={What is the best sequence of chemotherapy in advanced colorectal cancer? Final results of a five-arm study},
journal={CHEMOTHERAPY},
volume={52},
number={1},
pages={20-22},
document_type={Article},
} 

